Digital Infuzion News

Digital Infuzion Achieves CIOReview Ranking for 20 Most Promising Biotech Technology Solution Providers 2016

GAITHERSBURG, MD—March 29, 2016 – Digital Infuzion is proud to have been named as one of the top 20 most promising biotech technology solution providers in 2016 by CIOReview.

This achievement is based on an evaluation by CEOs, CIOs, VCs, analysts, and CIOReview’s editorial board of Digital Infuzion’s specialties in Clinical Informatics, Observational Outcomes, Bioinformatics, CIO Support, Health Data Interoperability and Mobile Health. Digital Infuzion’s deep expertise in developing and applying IT tools and techniques to empower decision making and accelerate insights in biomedical informatics contributed to CIOReview’s selection.

“We live in an era of remarkable change and opportunity. The convergence of data and technology is transforming healthcare and Digital Infuzion is grateful to be able contribute bioinformatics solutions that empower patients and improve their outcomes” reflects Hemant Virkar, Digital Infuzion’s President and CEO. The featured article is available in print and online.

About CIOReview
Published from Fremont, California, CIOReview is a print magazine that explores and understands the plethora of ways adopted by firms to execute the smooth functioning of their businesses. A distinguished panel comprising of CEOs, CIOs, VCs, analysts including CIOReview editorial board finalized the “20 Most Promising Biotech Technology Solution Providers 2016” in the U.S. and shortlisted the best vendors and consultants. For more information click here.

About Digital Infuzion
Digital Infuzion is a custom biomedical informatics solutions provider. Working at the intersection of biology, medicine and technology, our deep understanding of these fields grants us the ability to offer the most innovative technology services and real-world solutions to the world's leading research centers and healthcare organizations. For more information click here.
0 Comments

Categories: All Digital Infuzion News, Corporate NewsNumber of views: 5455

Tags: